Cargando…
Nanocarriers for Skin Applications: Where Do We Stand?
Skin penetration of active molecules for treatment of diverse diseases is a major field of research owing to the advantages associated with the skin like easy accessibility, reduced systemic‐derived side effects, and increased therapeutic efficacy. Despite these advantages, dermal drug delivery is g...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292798/ https://www.ncbi.nlm.nih.gov/pubmed/34487599 http://dx.doi.org/10.1002/anie.202107960 |
_version_ | 1784749462904635392 |
---|---|
author | Tiwari, Neha Osorio‐Blanco, Ernesto Rafael Sonzogni, Ana Esporrín‐Ubieto, David Wang, Huiyi Calderón, Marcelo |
author_facet | Tiwari, Neha Osorio‐Blanco, Ernesto Rafael Sonzogni, Ana Esporrín‐Ubieto, David Wang, Huiyi Calderón, Marcelo |
author_sort | Tiwari, Neha |
collection | PubMed |
description | Skin penetration of active molecules for treatment of diverse diseases is a major field of research owing to the advantages associated with the skin like easy accessibility, reduced systemic‐derived side effects, and increased therapeutic efficacy. Despite these advantages, dermal drug delivery is generally challenging due to the low skin permeability of therapeutics. Although various methods have been developed to improve skin penetration and permeation of therapeutics, they are usually aggressive and could lead to irreversible damage to the stratum corneum. Nanosized carrier systems represent an alternative approach for current technologies, with minimal damage to the natural barrier function of skin. In this Review, the use of nanoparticles to deliver drug molecules, genetic material, and vaccines into the skin is discussed. In addition, nanotoxicology studies and the recent clinical development of nanoparticles are highlighted to shed light on their potential to undergo market translation. |
format | Online Article Text |
id | pubmed-9292798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92927982022-07-20 Nanocarriers for Skin Applications: Where Do We Stand? Tiwari, Neha Osorio‐Blanco, Ernesto Rafael Sonzogni, Ana Esporrín‐Ubieto, David Wang, Huiyi Calderón, Marcelo Angew Chem Int Ed Engl Reviews Skin penetration of active molecules for treatment of diverse diseases is a major field of research owing to the advantages associated with the skin like easy accessibility, reduced systemic‐derived side effects, and increased therapeutic efficacy. Despite these advantages, dermal drug delivery is generally challenging due to the low skin permeability of therapeutics. Although various methods have been developed to improve skin penetration and permeation of therapeutics, they are usually aggressive and could lead to irreversible damage to the stratum corneum. Nanosized carrier systems represent an alternative approach for current technologies, with minimal damage to the natural barrier function of skin. In this Review, the use of nanoparticles to deliver drug molecules, genetic material, and vaccines into the skin is discussed. In addition, nanotoxicology studies and the recent clinical development of nanoparticles are highlighted to shed light on their potential to undergo market translation. John Wiley and Sons Inc. 2021-10-01 2022-01-17 /pmc/articles/PMC9292798/ /pubmed/34487599 http://dx.doi.org/10.1002/anie.202107960 Text en © 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Reviews Tiwari, Neha Osorio‐Blanco, Ernesto Rafael Sonzogni, Ana Esporrín‐Ubieto, David Wang, Huiyi Calderón, Marcelo Nanocarriers for Skin Applications: Where Do We Stand? |
title | Nanocarriers for Skin Applications: Where Do We Stand? |
title_full | Nanocarriers for Skin Applications: Where Do We Stand? |
title_fullStr | Nanocarriers for Skin Applications: Where Do We Stand? |
title_full_unstemmed | Nanocarriers for Skin Applications: Where Do We Stand? |
title_short | Nanocarriers for Skin Applications: Where Do We Stand? |
title_sort | nanocarriers for skin applications: where do we stand? |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292798/ https://www.ncbi.nlm.nih.gov/pubmed/34487599 http://dx.doi.org/10.1002/anie.202107960 |
work_keys_str_mv | AT tiwarineha nanocarriersforskinapplicationswheredowestand AT osorioblancoernestorafael nanocarriersforskinapplicationswheredowestand AT sonzogniana nanocarriersforskinapplicationswheredowestand AT esporrinubietodavid nanocarriersforskinapplicationswheredowestand AT wanghuiyi nanocarriersforskinapplicationswheredowestand AT calderonmarcelo nanocarriersforskinapplicationswheredowestand |